ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics™.
ActoBiotics™ are created using TopAct™, ActoGeniX’s versatile and proprietary technology platform. They can be orally administered and target receptors and pathways in gastrointestinal tissues. This novel class of biopharmaceuticals has the potential to treat a broad range of severe diseases.
With several ActoBiotics™ in various stages of clinical and preclinical development, ActoGeniX’s initial focus is on areas with unmet need in gastrointestinal, immunological and metabolic diseases.
Company Details
- Address
- Technologiepark 4, Zwijnaarde,9052,belgium
- Phone
- 32 9 261 06 00
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- actogenix.com
- Keywords
- Olymp Advisors Brussels.
- HQ
- Zwijnaarde
Actogenix N.v. Questions
Actogenix N.V.'s helpline number is 32 9 261 06 00
Actogenix N.V.'s website is actogenix.com
Actogenix N.V.'s LinkedIn profile is https://be.linkedin.com/company/actogenix-n.v.
Actogenix N.V.'s industry is
Biotechnology Research
Actogenix N.V.'s top competitors are
Intrexon Actobiotics N.v.,
Social Seeder,
Pliant Therapeutics,
Intrexon Corporation,
Mendor,
Olymp Advisors Brussels,
Septerna,
Protealis,
Hydrofix,
Signore Distillery.
Actogenix N.V.'s categories are Biotechnology Research
